PIK3CA and neoplasm: Another mechanism of sensitivity to immune checkpoint inhibitors caused by PIK3CA gene mutations is that they can increase the TMB, resulting in more neoantigens and enhancing the immunogenicity of the tumor to increase sensitivity to immune checkpoint inhibitors (Westcott et al., 2023).